PO.MCB04.01 · 分子与细胞生物学
慢性暴露于酸性pH对MOLM-13急性髓系白血病细胞系的影响
Effect of chronic exposure to acidic pH on the MOLM-13 acute myeloid leukemia cell line
作者与单位 Authors & Affiliations
摘要 Abstract
中文摘要
细胞外微环境酸化(pHe ≈ 6.4-6.8)构成癌症中一种主要的代谢应激,可促进免疫逃逸、肿瘤进展和治疗耐药。我们实验室此前已证明钙信号在白血病细胞耐药机制中的关键作用。急性髓系白血病(AML)是一种复发率高的恶性血液系统疾病,通过白血病干细胞的持续存在、对凋亡的抵抗以及外排泵活性增强,典型地体现了这一问题。此外,Warburg效应驱动细胞外酸中毒,有利于侵袭性、治疗耐药表型的出现,并改变支持存活和增殖的细胞内代谢和信号通路。
本研究旨在确定长期暴露于酸性细胞外pH是否会改变白血病细胞的钙信号特征,并促进AML的适应性耐药机制。实验采用MOLM-13细胞系进行,该细胞系源自一例携带FLT3串联重复的复发病例。将细胞在酸性(pHe ≈ 6.5)或中性(pHe ≈ 7.4)pH条件下培养三周以诱导表型适应。流式细胞术分析评估活力和凋亡(Annexin V/IP)、细胞周期分布(Ki67/IP)以及白血病干细胞比例(CD34⁺/CD38⁻)。使用特异性荧光探针实时监测细胞内钙动态和细胞内pH,同时通过罗丹明外排法定量外排泵活性。通过qPCR评估与钙稳态和pH调节相关的基因表达,以评估对慢性酸应激的转录适应。
初步结果表明,慢性暴露于酸性pH既不损害细胞活力,也不诱导凋亡或坏死。细胞周期分析显示G₀期和S期增加,以G₁期为主,同时干性细胞比例降低。细胞内pH、钙库和容量性钙内流均降低,而外排泵活性下降约10%。在转录水平上,NFATc1、STIM2和PMCA4下调,而ORAI1过表达,提示在持续酸中毒的应答中激活了适应性或耐药机制,这可能支持残留白血病细胞在代谢应激下的存活。
尽管是初步结果,这些发现凸显了慢性细胞外酸化对钙信号及白血病细胞适应能力的显著影响。进一步的研究,包括精确的细胞内pH定量、延长酸暴露时间,以及对来自不同突变背景的原代AML样本的分析,将完善这些观察结果,并最终可能有助于鉴定新型的钙相关功能性生物标志物和潜在治疗靶点,以克服AML中的耐药。
查看英文原文 English abstract
Acidification of the extracellular microenvironment (pHe ≈ 6.4-6.8) constitutes a major metabolic stress in cancers, promoting immune evasion, tumor progression, and therapy resistance. In our laboratory, we previously demonstrated the pivotal role of calcium signaling in the resistance mechanisms of leukemic cells. Acute myeloid leukemia (AML), a malignant hematologic disorder with a high relapse rate, exemplifies this issue through the persistence of leukemic stem cells, resistance to apoptosis, and enhanced efflux pump activity. Furthermore, the Warburg effect drives extracellular acidosis, favouring the emergence of aggressive, therapy-resistant phenotypes and altering intracellular metabolic and signaling pathways that support survival and proliferation.
This study aimed to determine whether prolonged exposure to acidic extracellular pH modifies the calcium signature of leukemic cells and contributes to adaptive resistance mechanisms in AML. Experiments were conducted on the MOLM-13 cell line, derived from a relapse case harboring an FLT3 tandem duplication. Cells were cultured for three weeks at acidic (pHe ≈ 6.5) or neutral (pHe ≈ 7.4) pH conditions to induce phenotypic adaptation. Flow cytometry analyses assessed viability and apoptosis (Annexin V/IP), cell-cycle distribution (Ki67/IP), and the leukemic stem cell fraction (CD34⁺/CD38⁻). Intracellular calcium dynamics and intracellular pH were monitored in real time using specific fluorescent probes, while efflux pump activity was quantified by rhodamine exclusion. Gene expression related to calcium homeostasis and pH regulation was evaluated by qPCR to assess transcriptional adaptations to chronic acid stress.
Preliminary results indicate that chronic exposure to acidic pH does not impair viability nor induce apoptosis or necrosis. Cell-cycle analysis shows increased G₀ and S phases with G₁ predominance, accompanied by a reduction in the stem-like fraction. Intracellular pH, calcium stores, and capacitive calcium influx are reduced, whereas efflux pump activity declines by approximately 10%. At the transcriptional level, NFATc1, STIM2, and PMCA4 are downregulated, whereas ORAI1 is overexpressed, suggesting the activation of adaptive or resistance mechanisms in response to sustained acidosis, which may support the survival of residual leukemic cells under metabolic stress.
Although preliminary, these findings highlight the significant impact of chronic extracellular acidification on calcium signaling and the adaptive capacities of leukemic cells. Further investigations, including precise intracellular pH quantification, extended acid exposure, and analyses of primary AML samples from diverse mutational backgrounds, will refine these observations and may ultimately facilitate the identification of novel calcium-related functional biomarkers and potential therapeutic targets to overcome resistance in AML.
利益披露 Disclosure
A. Guillemette, None..
E. Gez, None..
S. Titah, None..
C. Berthon, None..
L. Goursaud, None..
N. Jouy, None..
L. Lemonnier, None..
S. Manier, None..
C. Brinster, None..
S. Mitra, None..
B. Quesnel, None..
Y. Touil, None.